João Marcos Salge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
João Marcos Salge has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Roberto Ribeiro Carvalho
Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sâo Paulo, Sâo Paulo, Brazil
5 shared publications - Bruno Guedes Baldi
Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sâo Paulo, Sâo Paulo, Brazil
4 shared publications - Alberto Cukier
Divisão de Pneumologia, Instituto do Coração - InCor - Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil
2 shared publications - André Luis Pereira de Albuquerque
Divisão de Pneumologia, Instituto do Coração - InCor - Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil
2 shared publications - Celso Ricardo Fernandes Carvalho
University of São Paulo
2 shared publications - Claudio Roberto Cernea
Head and Neck Service ICESP Sao Paulo Brazil
2 shared publications
Latest Publications
- Open Access
- 11 September 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (1)
Mechanisms of exercise limitation and prevalence of pulmonary hypertension in hypersensitivity pneumonitis
Background: Hypersensitivity pneumonitis (HP) is an immune-mediated condition triggered by inhaled antigens in susceptible individuals. Patients with HP often present with exercise limitation due to multiple mechanisms, including ventilatory and cardiocirculatory impairments, particularly pulmonary hypertension (PH). Methods: In this cross-sectional study, patients with HP of varying severity underwent clinical assessment, including quality-of-life questionnaires, incremental treadmill cardiopulmonary exercise testing (CPET), pulmonary function testing, 6-min walk test and transthoracic echocardiography (TTE). Patients with a diffusing capacity of the lung for carbon monoxide ( D LCO ) below 40% of predicted and/or a tricuspid regurgitation velocity >2.5 m·s −1 or pulmonary artery systolic pressure >35 mmHg on TTE were referred for right heart catheterisation. Results: Among 90 patients, 65% were female, with a median age of 65.5 years, and 85% had fibrotic HP. CPET was performed in 51 patients (56%), with a mean peak oxygen consumption of 58±13% of predicted. Exercise capacity was reduced in 98% of patients, with multifactorial limitation in 88%, primarily due to cardiocirculatory impairment (76%) and impaired gas exchange (66%). The mean 6-min walk distance was 334±116 m. Mean forced vital capacity and D LCO were 56±20% and 42±22% predicted, respectively. PH was identified in 59% of patients (95% CI 48–72%), predominantly with combined post- and pre-capillary involvement. Conclusions: Reduced exercise capacity is highly prevalent in patients with HP and is typically multifactorial. PH is also common, with a predominance of combined post- and pre-capillary patterns. These findings underscore the need for a comprehensive evaluation strategy in symptomatic HP patients.
- 11 September 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (1)
Open AccessMechanisms of exercise limitation and prevalence of pulmonary hypertension in hypersensitivity pneumonitis
Background: Hypersensitivity pneumonitis (HP) is an immune-mediated condition triggered by inhaled antigens in susceptible individuals. Patients with HP often present with exercise limitation due to multiple mechanisms, including ventilatory and cardiocirculatory impairments, particularly pulmonary hypertension (PH). Methods: In this cross-sectional study, patients with HP of varying severity underwent clinical assessment, including quality-of-life questionnaires, incremental treadmill cardiopulmonary exercise testing (CPET), pulmonary function testing, 6-min walk test and transthoracic echocardiography (TTE). Patients with a diffusing capacity of the lung for carbon monoxide ( D LCO ) below 40% of predicted and/or a tricuspid regurgitation velocity >2.5 m·s −1 or pulmonary artery systolic pressure >35 mmHg on TTE were referred for right heart catheterisation. Results: Among 90 patients, 65% were female, with a median age of 65.5 years, and 85% had fibrotic HP. CPET was performed in 51 patients (56%), with a mean peak oxygen consumption of 58±13% of predicted. Exercise capacity was reduced in 98% of patients, with multifactorial limitation in 88%, primarily due to cardiocirculatory impairment (76%) and impaired gas exchange (66%). The mean 6-min walk distance was 334±116 m. Mean forced vital capacity and D LCO were 56±20% and 42±22% predicted, respectively. PH was identified in 59% of patients (95% CI 48–72%), predominantly with combined post- and pre-capillary involvement. Conclusions: Reduced exercise capacity is highly prevalent in patients with HP and is typically multifactorial. PH is also common, with a predominance of combined post- and pre-capillary patterns. These findings underscore the need for a comprehensive evaluation strategy in symptomatic HP patients.
- 6 May 2025
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- p. 1-15
Mechanisms of exercise limitation and pulmonary rehabilitation in patients with cystic lung diseases
The main diffuse cystic lung diseases (DCLD) include lymphangioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis (PLCH), Birt-Hogg-Dubé syndrome, and lymphocytic interstitial pneumonia. Exercise limitationis frequent and secondary to multiple mechanisms in DCLD. Some studies addressed mechanisms for exercise limitation, field tests, and pulmonary rehabilitation (PR) in DCLD. This review aims to present the main mechanisms that determine exercise limitation, the responses of patients in field tests, and the details regarding the safety and efficacy of PR in DCLD, with emphasis on LAM and PLCH. A search on the issue was performed in the MEDLINE and SciELO databases between 27 November 2024 and 20 February 2025. Manuscripts were reviewed and important topics were included in this review. Reduced exercise capacity is common and multifactorial, including ventilatory, cardiocirculatory, and peripheral limitations, pulmonary hypertension (PH), and impaired gas exchange in LAM and PLCH. Variables from field tests are correlated with pulmonary function tests, and PR is safe and beneficial in LAM. Further studies are necessary to evaluate exercise in other DCLDs, the impact of other therapeutic modalities on DH, hypoxemia, and exercise-induced PH in LAM and PLCH, and the safety and benefits of PR mostly in PLCH.
- 6 May 2025
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- p. 1-15
Mechanisms of exercise limitation and pulmonary rehabilitation in patients with cystic lung diseases
The main diffuse cystic lung diseases (DCLD) include lymphangioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis (PLCH), Birt-Hogg-Dubé syndrome, and lymphocytic interstitial pneumonia. Exercise limitationis frequent and secondary to multiple mechanisms in DCLD. Some studies addressed mechanisms for exercise limitation, field tests, and pulmonary rehabilitation (PR) in DCLD. This review aims to present the main mechanisms that determine exercise limitation, the responses of patients in field tests, and the details regarding the safety and efficacy of PR in DCLD, with emphasis on LAM and PLCH. A search on the issue was performed in the MEDLINE and SciELO databases between 27 November 2024 and 20 February 2025. Manuscripts were reviewed and important topics were included in this review. Reduced exercise capacity is common and multifactorial, including ventilatory, cardiocirculatory, and peripheral limitations, pulmonary hypertension (PH), and impaired gas exchange in LAM and PLCH. Variables from field tests are correlated with pulmonary function tests, and PR is safe and beneficial in LAM. Further studies are necessary to evaluate exercise in other DCLDs, the impact of other therapeutic modalities on DH, hypoxemia, and exercise-induced PH in LAM and PLCH, and the safety and benefits of PR mostly in PLCH.
- Open Access
- 20 December 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (6) , e20240169
New spirometry recommendations from the Brazilian Thoracic Association – 2024 update
The latest pulmonary function guideline from the Brazilian Thoracic Association was published in 2002, since which there have been updates to international guidelines (mainly those from the European Respiratory Society and the American Thoracic Society), as well as new national and international publications on various aspects of the performance, interpretation, and clinical implications of spirometry. Despite those updates, a careful analysis of what applies to the reality in Brazil is essential, because there have been studies that evaluated individuals who are representative of our population and who could show responses different from those of individuals in other regions of the world. This document is the result of the work of a group of specialists in pulmonary function who evaluated relevant scientific articles that could be applicable to the population of Brazil. After the discussions, new spirometry guidelines were drawn up, covering various aspects such as its technical parameters and performance; its indications and contraindications; its interpretation; concepts of normality and their related variability; reference values; classification of functional severity; and response to an inhaled bronchodilator. Finally, the guidelines emphasize the need to always interpret spirometry results in the context of the clinical condition of the patient and of the pretest probability.
- 20 December 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (6) , e20240169
Open AccessNew spirometry recommendations from the Brazilian Thoracic Association – 2024 update
The latest pulmonary function guideline from the Brazilian Thoracic Association was published in 2002, since which there have been updates to international guidelines (mainly those from the European Respiratory Society and the American Thoracic Society), as well as new national and international publications on various aspects of the performance, interpretation, and clinical implications of spirometry. Despite those updates, a careful analysis of what applies to the reality in Brazil is essential, because there have been studies that evaluated individuals who are representative of our population and who could show responses different from those of individuals in other regions of the world. This document is the result of the work of a group of specialists in pulmonary function who evaluated relevant scientific articles that could be applicable to the population of Brazil. After the discussions, new spirometry guidelines were drawn up, covering various aspects such as its technical parameters and performance; its indications and contraindications; its interpretation; concepts of normality and their related variability; reference values; classification of functional severity; and response to an inhaled bronchodilator. Finally, the guidelines emphasize the need to always interpret spirometry results in the context of the clinical condition of the patient and of the pretest probability.
- Open Access
- 31 October 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (5) , e20210208
Acute exacerbation of post-COVID-19 pulmonary fibrosis: air travel as a potential trigger
- 31 October 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (5) , e20210208
Open AccessAcute exacerbation of post-COVID-19 pulmonary fibrosis: air travel as a potential trigger
- 25 January 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 59 (6) , 1272-1278
Preoperative evaluation for lung resection in patients with bronchiectasis: should we rely on standard lung function evaluation?
The scant data about non-cystic fibrosis bronchiectasis, including tuberculosis sequelae and impairment of lung function, can bias the preoperative physiological assessment. Our goal was to evaluate the changes in lung function and exercise capacity following pulmonary resection in these patients; we also looked for outcome predictors. We performed a non-randomized prospective study evaluating lung function changes in patients with non-cystic fibrosis bronchiectasis treated with pulmonary resection. Patients performed lung function tests and cardiopulmonary exercise tests preoperatively and 3 and 9 months after the operation. Demographic data, comorbidities, surgical data and complications were collected. Forty-four patients were evaluated for lung function. After resection, the patients had slightly lower values for spirometry: forced expiratory volume in 1 s preoperatively: 2.21 l ± 0.8; at 3 months: 1.9 l ± 0.8 and at 9 months: 2.0 l ± 0.8, but the relationship between the forced expiratory volume in 1 s and the forced vital capacity remained. The gas diffusion measured by diffusing capacity for carbon monoxide did not change: preoperative value: 23.2 ml/min/mmHg ± 7.4; at 3 months: 21.5 ml/min/mmHg ± 5.6; and at 9 months: 21.7 ml/min/mmHg ± 8.2. The performance of general exercise did not change; peak oxygen consumption preoperatively was 20.9 ml/kg/min ± 7.4; at 3 months: 19.3 ml/kg/min ± 6.4; and at 9 months: 20.2 ml/kg/min ± 8.0. Forty-six patients were included for analysis of complications. We had 13 complications with 2 deaths. To test the capacity of the predicted postoperative (PPO) values to forecast complications, we performed several multivariate and univariate analyses; none of them was a significant predictor of complications. When we analysed other variables, only bronchoalveolar lavage with positive culture was significant for postoperative complications (P = 0.0023). Patients who had a pneumonectomy had a longer stay in the intensive care unit (P = 0.0348). The calculated PPO forced expiratory volume in 1 s had an excellent correlation with the measurements at 3 and 9 months; but the calculated PPO capacity for carbon monoxide and the PPO peak oxygen consumption slightly underestimated the 3- and 9-month values. However, none of them was a predictor for complications. Better tools to predict postoperative complications for patients with bronchiectasis who are candidates for lung resection are needed. Clinicaltrials.gov: NCT01268475
- 25 January 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 59 (6) , 1272-1278
Preoperative evaluation for lung resection in patients with bronchiectasis: should we rely on standard lung function evaluation?
The scant data about non-cystic fibrosis bronchiectasis, including tuberculosis sequelae and impairment of lung function, can bias the preoperative physiological assessment. Our goal was to evaluate the changes in lung function and exercise capacity following pulmonary resection in these patients; we also looked for outcome predictors. We performed a non-randomized prospective study evaluating lung function changes in patients with non-cystic fibrosis bronchiectasis treated with pulmonary resection. Patients performed lung function tests and cardiopulmonary exercise tests preoperatively and 3 and 9 months after the operation. Demographic data, comorbidities, surgical data and complications were collected. Forty-four patients were evaluated for lung function. After resection, the patients had slightly lower values for spirometry: forced expiratory volume in 1 s preoperatively: 2.21 l ± 0.8; at 3 months: 1.9 l ± 0.8 and at 9 months: 2.0 l ± 0.8, but the relationship between the forced expiratory volume in 1 s and the forced vital capacity remained. The gas diffusion measured by diffusing capacity for carbon monoxide did not change: preoperative value: 23.2 ml/min/mmHg ± 7.4; at 3 months: 21.5 ml/min/mmHg ± 5.6; and at 9 months: 21.7 ml/min/mmHg ± 8.2. The performance of general exercise did not change; peak oxygen consumption preoperatively was 20.9 ml/kg/min ± 7.4; at 3 months: 19.3 ml/kg/min ± 6.4; and at 9 months: 20.2 ml/kg/min ± 8.0. Forty-six patients were included for analysis of complications. We had 13 complications with 2 deaths. To test the capacity of the predicted postoperative (PPO) values to forecast complications, we performed several multivariate and univariate analyses; none of them was a significant predictor of complications. When we analysed other variables, only bronchoalveolar lavage with positive culture was significant for postoperative complications (P = 0.0023). Patients who had a pneumonectomy had a longer stay in the intensive care unit (P = 0.0348). The calculated PPO forced expiratory volume in 1 s had an excellent correlation with the measurements at 3 and 9 months; but the calculated PPO capacity for carbon monoxide and the PPO peak oxygen consumption slightly underestimated the 3- and 9-month values. However, none of them was a predictor for complications. Better tools to predict postoperative complications for patients with bronchiectasis who are candidates for lung resection are needed. Clinicaltrials.gov: NCT01268475
- Open Access
- 1 January 2020
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 46 (5) , e20190162
Characterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects
Objective: To characterize a population of patients with bronchiectasis, correlating clinical, radiological, and functional aspects with the severity of dyspnea. Methods: This was a cross-sectional study involving adult patients with HRCT-confirmed bronchiectasis, categorized according to the severity of dyspnea (as being mildly or severely symptomatic, on the basis of the modified Medical Research Council scale). We correlated the severity of dyspnea with clinical parameters, functional parameters (spirometry values, lung volumes, and DLCO), and CT parameters. Results: We evaluated 114 patients, 47 (41%) of whom were men. The median age (interquartile range) was 42 years (30-55 years). The most common form was idiopathic bronchiectasis. Of the 114 patients, 20 (17.5%) were colonized with Pseudomonas aeruginosa and 59 (51.8%) were under continuous treatment with macrolides. When we applied the Exacerbation in the previous year, FEV1, Age, Colonization, Extension, and Dyspnea score, the severity of dyspnea was categorized as moderate in 54 patients (47.4%), whereas it was categorized as mild in 50 (43.9%) when we applied the Bronchiectasis Severity Index. The most common lung function pattern was one of obstruction, seen in 95 patients (83.3%), and air trapping was seen in 77 patients (68.7%). The prevalence of an obstructive pattern on spirometry was higher among the patients with dyspnea that was more severe, and most functional parameters showed reasonable accuracy in discriminating between levels of dyspnea severity. Conclusions: Patients with bronchiectasis and dyspnea that was more severe had greater functional impairment. The measurement of lung volumes complemented the spirometry data. Because bronchiectasis is a complex, heterogeneous condition, a single variable does not seem to be sufficient to provide an overall characterization of the clinical condition.
- 1 January 2020
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 46 (5) , e20190162
Open AccessCharacterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects
Objective: To characterize a population of patients with bronchiectasis, correlating clinical, radiological, and functional aspects with the severity of dyspnea. Methods: This was a cross-sectional study involving adult patients with HRCT-confirmed bronchiectasis, categorized according to the severity of dyspnea (as being mildly or severely symptomatic, on the basis of the modified Medical Research Council scale). We correlated the severity of dyspnea with clinical parameters, functional parameters (spirometry values, lung volumes, and DLCO), and CT parameters. Results: We evaluated 114 patients, 47 (41%) of whom were men. The median age (interquartile range) was 42 years (30-55 years). The most common form was idiopathic bronchiectasis. Of the 114 patients, 20 (17.5%) were colonized with Pseudomonas aeruginosa and 59 (51.8%) were under continuous treatment with macrolides. When we applied the Exacerbation in the previous year, FEV1, Age, Colonization, Extension, and Dyspnea score, the severity of dyspnea was categorized as moderate in 54 patients (47.4%), whereas it was categorized as mild in 50 (43.9%) when we applied the Bronchiectasis Severity Index. The most common lung function pattern was one of obstruction, seen in 95 patients (83.3%), and air trapping was seen in 77 patients (68.7%). The prevalence of an obstructive pattern on spirometry was higher among the patients with dyspnea that was more severe, and most functional parameters showed reasonable accuracy in discriminating between levels of dyspnea severity. Conclusions: Patients with bronchiectasis and dyspnea that was more severe had greater functional impairment. The measurement of lung volumes complemented the spirometry data. Because bronchiectasis is a complex, heterogeneous condition, a single variable does not seem to be sufficient to provide an overall characterization of the clinical condition.
- 1 September 2019
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 85 (5) , 623-627
Evaluation of lung function in patients submitted to total laryngectomy
- 1 September 2019
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 85 (5) , 623-627
Evaluation of lung function in patients submitted to total laryngectomy
- Open Access
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (6) , 469-476
Impact of thoracic radiotherapy on respiratory function and exercise capacity in patients with breast cancer
Objective: To evaluate the impact of thoracic radiotherapy on respiratory function and exercise capacity in patients with breast cancer. Methods: Breast cancer patients in whom thoracic radiotherapy was indicated after surgical treatment and chemotherapy were submitted to HRCT, respiratory evaluation, and exercise capacity evaluation before radiotherapy and at three months after treatment completion. Respiratory muscle strength testing, measurement of chest wall mobility, and complete pulmonary function testing were performed for respiratory evaluation; cardiopulmonary exercise testing was performed to evaluate exercise capacity. The total radiotherapy dose was 50.4 Gy (1.8 Gy/fraction) to the breast or chest wall, including supraclavicular lymph nodes (SCLN) or not. Dose-volume histograms were calculated for each patient with special attention to the ipsilateral lung volume receiving 25 Gy (V25), in absolute and relative values, and mean lung dose. Results: The study comprised 37 patients. After radiotherapy, significant decreases were observed in respiratory muscle strength, chest wall mobility, exercise capacity, and pulmonary function test results (p < 0.05). DLCO was unchanged. HRCT showed changes related to radiotherapy in 87% of the patients, which was more evident in the patients submitted to SCLN irradiation. V25% significantly correlated with radiation pneumonitis. Conclusions: In our sample of patients with breast cancer, thoracic radiotherapy seemed to have caused significant losses in respiratory and exercise capacity, probably due to chest wall restriction; SCLN irradiation represented an additional risk factor for the development of radiation pneumonitis.
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (6) , 469-476
Open AccessImpact of thoracic radiotherapy on respiratory function and exercise capacity in patients with breast cancer
Objective: To evaluate the impact of thoracic radiotherapy on respiratory function and exercise capacity in patients with breast cancer. Methods: Breast cancer patients in whom thoracic radiotherapy was indicated after surgical treatment and chemotherapy were submitted to HRCT, respiratory evaluation, and exercise capacity evaluation before radiotherapy and at three months after treatment completion. Respiratory muscle strength testing, measurement of chest wall mobility, and complete pulmonary function testing were performed for respiratory evaluation; cardiopulmonary exercise testing was performed to evaluate exercise capacity. The total radiotherapy dose was 50.4 Gy (1.8 Gy/fraction) to the breast or chest wall, including supraclavicular lymph nodes (SCLN) or not. Dose-volume histograms were calculated for each patient with special attention to the ipsilateral lung volume receiving 25 Gy (V25), in absolute and relative values, and mean lung dose. Results: The study comprised 37 patients. After radiotherapy, significant decreases were observed in respiratory muscle strength, chest wall mobility, exercise capacity, and pulmonary function test results (p < 0.05). DLCO was unchanged. HRCT showed changes related to radiotherapy in 87% of the patients, which was more evident in the patients submitted to SCLN irradiation. V25% significantly correlated with radiation pneumonitis. Conclusions: In our sample of patients with breast cancer, thoracic radiotherapy seemed to have caused significant losses in respiratory and exercise capacity, probably due to chest wall restriction; SCLN irradiation represented an additional risk factor for the development of radiation pneumonitis.
- Open Access
- 1 August 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (4) , 299-306
Spirometry in patients screened for coronary artery disease: is it useful?
Objective: To determine the prevalence of spirometric abnormalities in patients screened for coronary artery disease (CAD) and the risk factors for lung function impairment. Methods: Patients referred for cardiac CT underwent spirometry and were subsequently divided into two groups, namely normal lung function and abnormal lung function. The prevalence of spirometric abnormalities was calculated for the following subgroups of patients: smokers, patients with metabolic syndrome, elderly patients, and patients with obstructive coronary lesions. All groups and subgroups were compared in terms of the coronary artery calcium score and the Duke CAD severity index. Results: A total of 205 patients completed the study. Of those, 147 (72%) had normal lung function and 58 (28%) had abnormal lung function. The median coronary artery calcium score was 1 for the patients with normal lung function and 36 for those with abnormal lung function (p = 0.01). The mean Duke CAD severity index was 15 for the former and 27 for the latter (p < 0.01). Being a smoker was associated with the highest OR for abnormal lung function, followed by being over 65 years of age and having obstructive coronary lesions. Conclusions: The prevalence of spirometric abnormalities appears to be high in patients undergoing cardiac CT for CAD screening. Smokers, elderly individuals, and patients with CAD are at an increased risk of lung function abnormalities and therefore should undergo spirometry. (ClinicalTrials.gov identifier: NCT01734629 [http://www.clinicaltrials.gov/])
- 1 August 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (4) , 299-306
Open AccessSpirometry in patients screened for coronary artery disease: is it useful?
Objective: To determine the prevalence of spirometric abnormalities in patients screened for coronary artery disease (CAD) and the risk factors for lung function impairment. Methods: Patients referred for cardiac CT underwent spirometry and were subsequently divided into two groups, namely normal lung function and abnormal lung function. The prevalence of spirometric abnormalities was calculated for the following subgroups of patients: smokers, patients with metabolic syndrome, elderly patients, and patients with obstructive coronary lesions. All groups and subgroups were compared in terms of the coronary artery calcium score and the Duke CAD severity index. Results: A total of 205 patients completed the study. Of those, 147 (72%) had normal lung function and 58 (28%) had abnormal lung function. The median coronary artery calcium score was 1 for the patients with normal lung function and 36 for those with abnormal lung function (p = 0.01). The mean Duke CAD severity index was 15 for the former and 27 for the latter (p < 0.01). Being a smoker was associated with the highest OR for abnormal lung function, followed by being over 65 years of age and having obstructive coronary lesions. Conclusions: The prevalence of spirometric abnormalities appears to be high in patients undergoing cardiac CT for CAD screening. Smokers, elderly individuals, and patients with CAD are at an increased risk of lung function abnormalities and therefore should undergo spirometry. (ClinicalTrials.gov identifier: NCT01734629 [http://www.clinicaltrials.gov/])
- Open Access
- 29 June 2018
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 85 (5) , 623-627
Evaluation of lung function in patients submitted to total laryngectomy
- 29 June 2018
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 85 (5) , 623-627
Open AccessEvaluation of lung function in patients submitted to total laryngectomy